DOW CHEMICAL CO /DE/ - FORM 8-K - February 19, 2010
| Attached files | ||||||
| File | Filename | |||||
|---|---|---|---|---|---|---|
| EX-1.1 - SELLING AGENT AGREEMENT - DOW CHEMICAL CO /DE/ | dex11.htm | |||||
| EX-4.1 - FORM OF DOW INTERNOTES(R) - DOW CHEMICAL CO /DE/ | dex41.htm | |||||
| EX-5.1 - OPINION OF DUNCAN A. STUART, ASSOCIATE GENERAL COUNSEL - DOW CHEMICAL CO /DE/ | dex51.htm | |||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant To Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) — February 19, 2010
The Dow Chemical Company
(Exact name of registrant as specified in its charter)
| Delaware | 1-3433 | 38-1285128 | ||
| (State or other jurisdiction) | (State or other jurisdiction) | (I.R.S. Employer of Incorporation Identification No.) |
| 2030 Dow Center Midland, Michigan |
48674 | |
| (Address of principal executive offices) | (Zip Code) |
(989) 636-1000
Registrant’s telephone number, including area code
N.A.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01. | Other Events. |
On February 19, 2010, The Dow Chemical Company (the “Company”) entered into a Selling Agent Agreement by and among the Company, Incapital LLC (as Purchasing Agent) and the agents named therein with respect to the sale by the Company of its InterNotes®.
Attached as exhibits to this Form 8-K are certain documents in connection with the Company’s InterNotes program for incorporation by reference in the Company’s Registration Statement on Form S-3 (No. 333-164985).
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
| 1.1 | Selling Agent Agreement, dated February 19, 2010, among The Dow Chemical Company, Incapital LLC (as Purchasing Agent) and the agents named therein | |
| 4.1 | Form of Dow InterNotes® | |
| 5.1 | Opinion of Duncan A. Stuart, Associate General Counsel—Corporate Transactions of The Dow Chemical Company | |
| 23.2 | Consent of Duncan A. Stuart (included in Exhibit 5.1) | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE DOW CHEMICAL COMPANY. | ||
| By: | /s/ William H. Weideman | |
| Name: William H. Weideman | ||
| Title: Vice President and Interim Chief Financial Officer | ||
DATE: February 19, 2010
3
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 1.1 | Selling Agent Agreement, dated February 19, 2010, among The Dow Chemical Company, Incapital LLC (as Purchasing Agent) and the agents named therein | |
| 4.1 | Form of Dow InterNotes® | |
| 5.1 | Opinion of Duncan A. Stuart, Associate General Counsel—Corporate Transactions of The Dow Chemical Company | |
| 23.2 | Consent of Duncan A. Stuart (included in Exhibit 5.1) | |
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by DOW CHEMICAL CO /DE/ and has no official or unofficial affiliation with DOW CHEMICAL CO /DE/
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
